Stocks in Play

Aspreva Pharmaceuticals

10:21 AM EST - Aspreva Pharmaceuticals : announced it will be acquired by Swiss-based Galenica Group. Galenica will pay US$26 per share for a total value of US$915 million. Aspreva Pharmaceuticals shares T.ASV are trading up 3.48 at $25.00.